The role of asymmetric dimethylarginine (ADMA) and leptin in hypertensive patients

Atamer, A.Ilan, N.Kocyigit, Y.Toprak, G.Ozbay, M.Celik, Y.2024-04-242024-04-2420071567-5688https://doi.org/10.1016/S1567-5688(07)71407-1https://hdl.handle.net/11468/1635876th Congress of the European-Atherosclerosis-Society -- JUN 10-13, 2007 -- Helsinki, FINLAND[Abstract Not Available]eninfo:eu-repo/semantics/closedAccessHypertensionLeptinAdmaInsulin ResistanceMdaLipoproteinsThe role of asymmetric dimethylarginine (ADMA) and leptin in hypertensive patientsThe role of asymmetric dimethylarginine (ADMA) and leptin in hypertensive patientsConference Object81115115WOS:00024786910045910.1016/S1567-5688(07)71407-1Q1